miR-146a-5p is a negative regulator of NF-kB activation, which is increased in many cell types in RA patients such as CD4+ T cells, and Th17 cells, peripheral blood mononuclear cells, and synovial fibroblasts. Here, NFKB1 is linked to rheumatoid arthritis.